| Views | |
|---|---|
| TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms | 145 |
| April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | |
|---|---|---|---|---|---|---|---|
| TFE3 activation in a TSC1‐altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms | 6 | 0 | 6 | 8 | 4 | 13 | 1 |
| Views | |
|---|---|
| 2020_Schmiester_etal.pdf | 124 |
